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ABSTRACT
Background Data: The most frequent treatable vascular abnormality of the spinal canal is spinal dural
arteriovenous fistulae (SDAVFs), which cause progressive para- or quadriplegia mostly affecting elderly
males. SDAVFs are present in the thoracolumbar region. The main goal of treatment must be to obliterate
the shunting zone via superselective embolization with the usage of a liquid embolic agent.
Purpose: This study aims to evaluate endovascular technique as a safe and efficient approach for the
treatment SDAVFs, especially with long-term follow-up clinical outcomes.
Study Design: A retrospective clinical case study.
Patients and Methods: From May 2010 to May 2017, 15 patients who had symptoms attributed to
SDAVFs underwent the operation in the Departments of Neurosurgery in Suhag, Tanta, and Al-Azhar
Universities and Interventional Radiology, Ain Shams University. All the patients had varying degrees of
progressive spastic paraparesis with and without sphincteric disturbances.
Results: Endovascular embolization was used in all cases. Fourteen were males, with ages ranging from
45 to 74 years old. After the treatment, good outcome was found in five patients (33.3%), a moderate
outcome was delineated in six patients (40 %), and four patients revealed a poor outcome (26.7%).
Conclusion: Spinal AVF could be treated safely and effectively by the endovascular approach. Generally,
there is no correlation between the disappearance of MRI abnormalities and significant clinical
improvement. The preclinical state of the patient is directly proportional to the clinical outcome. Due to
unexpected responses, embolization should be attempted even the patient is in a bad clinical condition.
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INTRODUCTION
Spinal vascular pathologies are considered rare.
They represent less than 2% of all vascular
neurological pathologies. 1,11 Among these lesions,
spinal dural arteriovenous fistulae (SDAVFs) are
by far the most common, accounting for around
80% of all spinal cases.5,15
SDAVFs mostly presented with back pain,
progressive weakness, variable degrees of sensory
deficits, and sphincteric problems. 1,18,23 The
pathophysiology of SDAVFs is mainly due to
elevated venous pressure resulting from shunting
of the blood from the arteries to the veins, which is
valveless, thus leading to reduction of the arterial
supply with progressive necrotizing myelopathy,
which may be irreversible if not treated. 9,10
The standard treatment for SDAVFs is usually
surgically because it is a technically feasible and
safe procedure with low rates of morbidity or
recurrence. Other treatment options include
endovascular embolization, which has achieved
rising acceptance, either alone or combined with
surgery.18,25
The aim of this study is to assess the efficacy and
safety of the embolization technique in treating
SDAVFs.

PATIENTS AND METHODS
We retrospectively reviewed patients with
symptoms due to SDAVFs in the period from May
2010 to May 2017 in Suhag, Tanta, Ain shams,
and Al-Azhar University Hospitals. Fifteen
patients were enrolled in this study with the mean
age of 54.2±10.3 (range, 45–74) years.
Inclusion criteria were all patients with
symptomatic SDAVFs confirmed by MRI and
diagnostic spinal angiogram (DSA). Exclusion
criteria were renal impairments, allergies to
IV contrast agents, and blood coagulopathies.
Patients that showed a shared artery supplying
both the anterior spinal artery and the fistula were
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excluded from the study; otherwise, embolization
was primarily attempted for all spinal DAVFs.
All patients were subjected to clinical evaluation
using the Aminoff–Logue motor disability scale
(Table 1).2
Table 1. Aminoff–Logue motor disability scale.2
Disability

Degree

Hypesthesia without gait restriction

1

Reduced tolerance to exercise

2

Need a cane for walking

3

Need for two canes or crutches to walk

4

Inability to stand: patient in a wheelchair
or in bed

5

According to the Aminoff–Logue scale, a good
result was defined as motor power of Grade 4 or
5, indicating that the patient can ambulate and
carry on with his daily activities (ALS1-ALS2);
a moderate result was defined as motor power of
Grade 3, indicating the patient needs support to
walk or perform activities (ALS3-ALS4); a poor
result was defined as motor power less than Grade
3 (ALS5) indicating the patient cannot perform
any activities.
The epidemiological and perioperative data of our
patients are summarized in Table 2. The Aminoff
scores were checked by a neurosurgeon team that
was not enrolled in the treatment plan.
Radiological assessments included noncontrast
MRI and postcontrast-enhanced MRI that
revealed flow void signals and cord increased
intensity on T2W imaging and postgadolinium
enhancement in all cases. Patients with findings
suspecting typical characteristics of SDAVFs were
scheduled for a conventional spinal angiogram. In
only 1 case in our series that was not eligible for
MRI due to placement of a cardiac pacemaker,
a thoracolumbar CT angiogram was used that
showed the appearance of the tortuous linear
vascular channel in the spinal canal. After the MRI
(or CTA) exam, all patients underwent a DSA; this
57
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was done directly before the endovascular therapy
in the same session.
The study was approved by the research ethics
committee of our institutions and informed
consent was obtained from each patient or their
guardians. The study was conducted according
to the WMA Declaration of Helsinki–Ethical
Principles for Medical Research Involving Human
Subjects.
Endovascular Procedure:
All patients underwent endovascular embolization
under general anesthesia. A 5 or 6 French (Fr)
femoral sheath is inserted, and a diagnostic
catheter of 5 Fr is employed. Various catheter
forms are frequently used during treatments;
the Cobra shape and SIM II are the most used
shapes because they may readily be placed into
the arterial branches of the spinal cord. Starting
with the internal iliac arteries and working up
to the right and left vertebral arteries, the entire
spinal vasculature is examined. Even though the
fistula was found at lower levels, this procedure
was followed to check any accompanying vascular
pathologies that might not be seen. Moreover, we
carefully evaluated the levels below and above
the fistula bilaterally to diagnose and treat any
additional feeders and check for the site of the
anterior spinal artery (artery of Adamkiewicz).
If the proximal vein draining the fistula (foot of
the vein) could be occluded with liquid embolic,
embolization was regarded as satisfactory. In all
cases, either Onyx or NBCA mixed with lipiodol
was used as a liquid embolic administered through
1.2 Fr or 1.5 Fr microcatheters after superselective
access of the involved radicular feeder arteries.
A control angiogram finally confirms the
disappearance of the SDAVFs.
Postprocedural follow-up included the following:
clinical evaluation after 2 weeks, 1 month, 3
months, 6 months, and 1 year using the Aminouff–
Louge scale comparing it with the preprocedure
score, radiological investigations by MRI with
contrast, and DSA after 1 month.
58

Statistical Analysis:
For statistical data analysis, IBM-SPSS, version 25
(IBM-Corporation, Chicago, USA; August 2017)
was utilized. Mean, standard deviation (SD),
number, and percentage were used to represent
the data. To compare the means of the Aminoff–
Logue motor disability scale, the paired t-test was
utilized.

RESULTS
A total of 15 patients with a mean age of 54.2±10.3
(range, 45–74) years, including 14 male patients
(93.3%) and one female, were recruited for this
study. All patients complained of progressive
spastic paraparesis of different grades (100%) and
eight patients (53.3%) had sphincter disturbances
(Table 2).
Embolization with NBCA was done in four
patients and Onyx in eleven patients. An arterial
spasm occurred during embolization in patient 1,
preventing the Onyx from getting to the vein. His
follow-up angiogram revealed a reestablishment
of the fistula (Table 3). Within two months, he
was scheduled for another endovascular trial
with Onyx re-embolization as he was surgically
unfit, and we managed to treat the fistula in the
second session. The fistulae in all patients were
found between D4 and L1, and the feeder, in these
cases, was a radicular artery. Fistulae arising from
the lateral sacral artery, which is a branch of the
internal iliac artery (IIA), were found in two cases:
at the L5 root in one and at the S1 root in another
one (Table 2).
The postembolization clinical result assessed
according to the Aminouff–Louge scale is seen in
Table 2. Five cases had a good result (33.3%), six
cases had moderate results (40 %), and four cases
had poor results (26.7%). The comparison of the
patient’s pre-embolization and postembolization
Aminouff–Louge scale scores showed a significant
impact on their outcome. Patients who had a
favorable outcome all had ALS level 3 before
treatment, which meant they could walk with
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Table 2. Summary of data of our study’s patients (n=15).
No Age Sex Presentation Diagnosis

Material

Aminoff–Logue scale

Sphincter
Preoperative Last follow-up control

1

47

M

Paraparesis,
Lt D4 SDAVFs
incontinence

Onyx

5

5

Not improved

2

67

M

Paraparesis

NBCA

3

2

-

3

47

M

Paraparesis,
Rt D12 SDAVFs
incontinence

Onyx

4

2

Not improved

4

51

M

Paraparesis,
Lt D8 SDAVFs
incontinence

Onyx

5

3

Improved

5

62

M

Paraparesis

Lt D10 SDAVFs

NBCA

5

5

-

6

51

M

Paraparesis

Rt D11 SDAVFs

Onyx

3

0

-

7

44

M

Lt L5 SDAVFs
Paraparesis,
lateral sacral artery
incontinence
from Left IIA

Onyx

3

2

Not improved

8

23

F

Paraparesis

Rt L4 SDAVFs

Onyx

3

0

Improved

9

62

M

Paraparesis

Rt D5 SDAVFs

Onyx

4

2

-

10 45

M

Paraparesis,
Lt D6 SDAVFs
incontinence

Onyx

5

5

Not improved

11 48

M

Paraparesis

Onyx

3

0

-

12 51

M

Paraparesis,
Rt D11 SDAVFs
incontinence

NBCA

5

4

Improved

13 47

M

Paraparesis,
Lt D10 SDAVFs
incontinence

Onyx

5

4

Improved

14 64

M

Paraparesis,
Lt D7 SDAVFs
incontinence

Onyx

5

5

Not improved

15 55

M

Paraparesis

3

0

-

Rt D4 SDAVFs

Lt D8 SDAVFs

Rt S1 SDAVFs
(origin: Rt lateral
NBCA
sacral artery, Rt IIA)

a support device and had good motor power
before treatment. Regarding the eight patients
with sphincter disturbances after treatment, three
patients (37.5%) improved, and five patients had
no improvement (62.5%).
It is crucial to mention that the case managed
by Onyx (patient 9) had reestablishment of the
fistula from a different level after three months
of angiogram follow-up, with no recent clinical
symptoms or even deterioration in his state at that
time, no obvious morbidity, recurrence (except
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patient 9), or even mortality during follow-up.
On postoperative angiograms and MRI after 1
month, all cases except the one who developed
arterial spasm had disappearance of the fistula on
DSA, the disappearance of the edema of the cord,
and signal void on MRI. However, there was no
relation between the resolution of MRI signs and
significant clinical improvement. Regarding longterm follow-up, we used the phone call interviews
to simplify and none of our 15 patients were
missed in our study follow-up.
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Figure 1. A 23-year-old female
patient presented with paraparesis
and sphincteric disturbance. (A) T2
sagittal MRI 2 areas of entangled flow
void signals inside the spinal canal
suggesting an etiology of high-flow
AV shunt; (B) red arrow: catheter in
the right 4th lumber artery, angiogram
showing high-flow AV fistula between
the radicular artery branch and the
spinal vein (blue arrow); (C) oblique
zoomed view of the radicular arterial
branch(red arrow) and the blue arrow
showing the foot of the vein in the
AV shunt; (D) arrow shows the tip
of the microcatheter at the fistulous
point; (E) postembolization Onyx cast
delineating the arterial feeder and the
foot of the vein; (F) arrow points to the
catheter in the lumber artery during a
control angiogram showing total cure
of the AV fistula; (G) postembolization
MRI showing marked reduction in
the size of the vascular channels 16
months later.

Figure 2. A 67-year-old male patient
presented with paraparesis. (A) CT
angiogram of thorax shows a tortuous
linear minute vascular channel in the
spinal canal suggesting high-flow AV
pathology; (B) red arrow shows the
guiding catheter and the microcatheter
accessing the right supreme intercostal
trunk. Angiogram showing multiple
radicular-dural arterial branches
shunting into the spinal vein (blue
arrow), with the latter assuming a
varicoid appearance, (C) control
angiogram via the guiding catheter
(red arrow) showing a cure of the
AV fistula, and (D) postembolization
CT showing the glue cast in the right
neural foramen 18 months later.
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DISCUSSION
SDAVFs are the direct connection between
an artery (radicular-meningeal) and a vein
(radicular-medullary).12,13 Up to 80% of spinal
vascular pathologies are caused by SDAVFs.17,14
The majority of cases of SDAVF are idiopathic,
yet acquired instances after trauma or surgery
were described.16,19 The most prevalent location
of occurrence is the thoracolumbar area, with
cervical SDAVFs being exceedingly rare. SDAVFs
affect men predominantly over 40 years, with a
ratio of male to female of 4:1.4 The pathogenesis
of myelopathy is a result of an increase in venous
pressure caused by arterial shunting to the vein,
leading to congestion in the spinal cord veins,
lowering the cord arterial perfusion pressure, and
finally causing cord ischemia and progressive
myelopathy that is nonreversible in its end-stage.6
That classic progression shows the following
exceptions: 5% to 15% of cases with SDAVFs
experience attacks of acute exacerbation of their
complaints known as the “Foix-Alajouanine
syndrome”; these attacks are thought to result
from sudden thrombosis of the diseased veins
draining the fistula; decline is unpredictable, and
nonreversible loss of function may occur except
if managed very early. In addition, a pattern of
the acute progressive buildup of the condition
with gaps of remission has been reported. If
the condition is not managed early, it will cause
progressive neurologic deterioration and marked
impairment in 2–3 years, eventually leading to
total paraplegia and incontinence.5,15
The primary imaging that indicates the presence
of the condition is MRI, which typically reveals a
tortuous pattern of signal void in the subarachnoid
region on T2-WI and a swollen edematous cord at
a certain level manifested by abnormal elevated
T2 intensity.1,12,19 In weeks and months following
surgery, removing the spinal AVF reduces spinal
cord edema, causes the disappearance of the
abnormal T2 increased intensity in the cord, and
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abolishes enhancement of the pathologic vessels
of the spinal venous plexus.19
The current study included 15 cases, with males
accounting for more than 90% of the cases
(14/14), which is in agreement with the studies of
Rashad et al.19 and Chibbaro et al.7 In the studies of
Gokhale et al.8 and Andres et al.3, males accounted
for 75% of the cases. The study of Ropper et al.21
showed less manifestation of male predominance
(11 males out of 15).
The age range of the current study is 45–74 years,
in agreement with the age range of Rashad et al.19
and Ropper et al.22 studies, where the age range of
the cases was 50–71 and 40–71 years, respectively.
According to Andres et al.3, the age range was
44–77 years. The age range of Chibbaro et al.7
and Gokhale et al.8 studies was wider (20–76 and
24–76 years, respectively).
Progressive motor weakness represents the most
common presentation of SDAVFs seen in up to
95% of patients, which is often associated with
neurogenic claudication (worsening of weakness
during physical exertion). Other manifestations
of SDAVFs include pain, numbness, sphincteric
disturbances, and sexual dysfunction.6
Regarding the presentation of the current
study cases, all cases with progressive spastic
paraparesis of different grades and 8 patients
(53.3%) had sphincter disturbances. According
to Ropper et al.21, the most common presentation
was weakness (87%), followed by numbness
(80%), paresthesia (60%), and bowel or bladder
symptoms (47%). In the study of Gokhale et
al.8, the most common presentation was back
pain (93%) and lower extremity weakness (85%).
Low back pain was the most common symptom
in Andres et al.’s study.3 According to Chibbaro
et al.7, the most common presentation was lower
extremity sensory disturbances (80%), followed by
paresthesia (60%), medullary claudication (30%),
paraplegia, and pain (20% each). In the study
of Rashad and colleagues, all cases presented with
progressive motor weakness (100%), followed by
sphincteric disturbances (75%) 19.
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The follow-up of the current study showed that
33.3% of them showed good improvement after
treatment, 40% showed moderate improvement
and 26.7% showed poor improvement. In the
study of Ropper et al.21 and colleagues 45% of the
cases improved after treatment, while 55% showed
no improvement. In the study of Rashad et al.19,
16.7% of the cases showed good improvement,
58.3% showed moderate improvement, and 25%
showed poor improvement. The failure rate of
Andres et al.3 cases was only 23.5%. On the other
hand, Chibbaro et al.7 claimed that they achieved
cure in 100% of their cases.
Embolization with liquid is reported to have
a very low rate of recurrence.9,3 In this series,
recanalization was encountered only in one
case (6.7% was related to spasm), and we never
delivered PVA in our case series. A reappearance
of the DAVF at another level was never seen in
our cases series except in one case (6.7%) based
on the repeated MRI exams and many clinical
follow-ups. The advantages of the embolization
technique are the noninvasive nature and the
option of an immediate angiogram test of the
treatment. For that reason, we postulated it as the
first choice in our study. Therefore, a primary trial
of embolization with liquid can be justified. In
this study, embolization did not push us through
surgery. Other spinal DAVF series were reported
by Ronald et al.20 (49 cases), Song et al.24 (27 cases),
and Safaee et al.22 (47 cases). In these studies, the
primary success rate of embolization with liquid
was reported between 30% and 90%. However,
Ronald et al.20 (90% primary success) stated that
entry of the liquid embolic into the fistula without
entry into the proximal vein is enough, which is
seen in the high recurrence rate of 23%. In Song
et al.’s24 study, the Aminoff score was applied in
35 treated patients, supported by our series by a
realization rate of 6.7% and a success rate of up
to 73.3%.
Our study limitations were the small sample
size due to the rarity of the pathology, being a
retrospective, the short radiological follow-up
62

period, and the study design being single arm with
no comparison to the surgical technique

CONCLUSION
Spinal AVF could be treated safely and effectively
by an endovascular approach. Generally, there
is no correlation between the disappearance
of MRI abnormalities and significant clinical
improvement. The preclinical state of the patient
is directly proportional to the clinical outcome. We
recommend the intervention even if the patient is
in bad clinical status because patients may show
dramatic clinical improvements in some situations.
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الملخص العربي
عـرض النتائـج اإلكلينيكيـة والمتابعـة طويلـة المـدى لمراكـز طبية متعـددة بخصوص عالج الوصالت الشـرياني
الوردية في غشاء االم الجافية بالحبل الشوكي عن طريق القسطرة

البيانات الخلفية :تعد الوصالت الشـريانية الوردية في الحبل الشـوكي اهم سـبب يمكن عالجه من أسـباب الشـلل
المرتبـط بالحبـل الشـوكي.وفـي أغلـب األوقـات تتواجـد الوصلـة فـي منطقـة الفقـرات الصدريـة و القطنيـة و يعـد
الهـدف مـن العلاج هـو غلـق منطقـة الوصلـة عـن الطريـق حـق مـادة صمغيـة مـن خلال قسـطرة دقيقـة توجـه إلـى
المكان المحدد باستخدام األشعة
الغـرض :إثبـات انـه علاج وصلات الحبـل الشـوكي الشـريانية الوريديـة علاج آمـن وفعـال خاصـة بعـد المتابعـة لفتـرة
طويلة.
تصميم الدراسة :دراسة حالة سريرية بأثر رجعي.

المرضى والطرق :تم عالج  ١٥مريض ؛  ١٤رجل وامراة تتراوح أعمارهم من سن  ٤٥عام إلى  ٧٤عام  ،تم عالجهم في
جامعات  :سـوهاج و طنطا واإلسـكندرية وعين شـمس  ،ويعانون من أعراض مرتبطة بوجود وصلة شـريانية وريدية
بالحبل الشوكي مثل شلل الساقين وعدم التحكم في البول او البراز

النتائـج  :تـم علاج الحـاالت جميعـا بالقسـطرة وكانـت النتيجـة أنـه خمسـة حـاالتتعافـوا تمامـا وسـتة حـاالت تعافـوا
جزئياً و أربع حاالت لم يتعافوا
الخالصة :إذا تم عالج الوصلة الشـريانية الوريدية في الحبل الشـوكي سـريعا سـتكون النتائج جيدة وهي تعافى تام.
حالـة المريـض قبـل الحقـن عنصـر رئيسـي فـي التنبـؤ بالنتيجـة .البـد مـن دراسـة الحالـة جيـدا قبـل العلاج .و يعـد علاج
القسطرة بديل مساوي للجراحة في العالج.
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